Addex Therapeutics Ltd (NASDAQ:ADXN)

0.6953
Delayed Data
As of Jun 02
 -0.0036 / -0.51%
Today’s Change
0.55
Today|||52-Week Range
4.33
+10.35%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Addex Therapeutics Ltd have a median target of 1.07, with a high estimate of 1.07 and a low estimate of 1.07. The median estimate represents a +54.38% increase from the last price of 0.70.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Outperform stock in Addex Therapeutics Ltd. This rating has held steady since December, when it was unchanged from a Outperform rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
$309.4K
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 84.63%
 
 
 
 
 
 
Growthannually 66.88%
 
 
 
 
 
 

Sales

Growthquarterly -44.88%
 
 
 
 
 
 
Growthannually 21.68%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.